Develops innovative treatments for the affections associated with degeneration of the peripheral nervous system (neuropathy)
Relief Therapeutics has raised €16M across 2 funding rounds from 1 investor, most recently a Growth/Late round in Jul 2021. Based in Geneva, Switzerland; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-07-26 | Growth/Late | €14M | — | View deal → |
| 2016-05-01 | Series A | €2.5M | Global Emerging Markets | View deal → |
